Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer

NCT04208958 is registered in ClinicalTrials.gov with Vedanta Biosciences, Inc. as lead sponsor.

NCT NCT04208958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04208958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
Lead sponsor
Vedanta Biosciences, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
January 23, 2020
Completion date
February 23, 2023
Enrollment
56 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, gastric cancer, gastroesophageal junction adenocarcinoma, melanoma, metastatic cancer